US Patent RE40812 Nasal calcitonin formulation
Patent RE40812 was granted and assigned to Unigene Laboratories, Inc. on June, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent RE40812 Nasal calcitonin formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
